Dddmag - dddmag.com - Drug Discovery & Development All
General Information:
Latest News:
Alcoholism Treatment Heads to Trial 27 Aug 2013 | 06:33 pm
The University of California, Los Angeles' (UCLA's) Departments of Psychology, and Psychiatry and Biobehavioral Sciences Brain Research Institute, and MediciNova Inc. a biopharmaceutical company, anno...
FDA Grants Priority Review to Nexavar 27 Aug 2013 | 06:22 pm
Bayer HealthCare and Onyx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation to the supplemental New Drug Application (sNDA) for the ora...
Merck KGaA Donating Shistosomiasis Meds to Sudan 27 Aug 2013 | 05:56 pm
Representatives of the German pharmaceutical, chemical and life science company Merck and the World Health Organization (WHO) launched the 2013 campaign to fight shistosomiasis in Sudan. This is the f...
Psoriasis Spray Does Well in Trial 27 Aug 2013 | 05:41 pm
Today Lipidor announced positive results from a phase 1/2a study investigating the efficacy and tolerability of its Akvano/calcipotriol spray formulation for the treatment of psoriasis vulgaris, the m...
Disabling Enzyme Cripples Cancer 27 Aug 2013 | 05:30 pm
Read more about Disabling Enzyme Cripples Cancer Comments
Compugen Names Advisory Board 27 Aug 2013 | 05:30 pm
Compugen Ltd., the Israeli drug developer, said that it has created a new panel to advise the company as it develops treatments in the immunology and oncology fields. The company's newly created s...
Warfarin May Up Heart Attack Risk 26 Aug 2013 | 10:30 pm
Read more about Warfarin May Up Heart Attack Risk Comments
Gene Silencing Keeps Mice Skinny 26 Aug 2013 | 10:30 pm
If candy and potato chips didn’t beckon from every street corner, wouldn’t we all be thin? Thankfully, science is looking at ways to resist. Read more about Gene Silencing Keeps Mice Skinny Comments
Scientists ID Biological Drug Target for Parkinson's 26 Aug 2013 | 10:30 pm
Researchers at Johns Hopkins and elsewhere have brought new clarity to the picture of what goes awry in the brain during Parkinson’s disease and identified a compound that eases the disease’s symptoms...
Takeda, Zinfandel Launch Phase 3 AD Trial 26 Aug 2013 | 10:30 pm
Takeda Pharmaceutical Company Limited and its partner, Zinfandel Pharmaceuticals Inc., announced the initiation of TOMMORROW, a global phase 3 clinical trial investigating a genetic-based biomarker ri...
